Citation Impact
Citing Papers
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)
2004
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Epidemiology of hepatitis B infection in the Western Pacific and South East Asia.
1996
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
A systematic review of delay in the diagnosis and treatment of tuberculosis
2008
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
1992
Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants
2002
Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?
1999
Vulvovaginal candidosis
2007 Standout
Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era
2008
FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM
1999
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
1998
Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease
2012
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Campylobacter jejuniInfection and Guillain–Barré Syndrome
1995
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
1998 Standout
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
Pulmonary disease among inpatient decedents: Impact of schizophrenia
2007
Guillain-Barré syndrome
2016 Standout
Comparative study of preceding Campylobacter jejuni infection in Guillain-Barre syndrome in Japan and The Netherlands
2001
Guillain–Barré Syndrome
2012 Standout
Regulation of hypoxia adaptation: an overlooked virulence attribute of pathogenic fungi?
2010
Hepatitis D: Scenario in the Asia-Pacific region
2010
Immunopathogenesis and treatment of the guillain–barré syndrome—part II
1995
Low Diversity Cryptococcus neoformans Variety grubii Multilocus Sequence Types from Thailand Are Consistent with an Ancestral African Origin
2011
Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A
2002
GUILLAIN-BARRE SYNDROME IN ORGAN AND BONE MARROW TRANSPLANT PATIENTS
2001
Biological roles of glycans
2016 Standout
Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis
2006
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disorders
1993
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Cryptococcosis
2006
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
1996
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
2004
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Cryptococcus gattii:in vitrosusceptibility to the new antifungal albaconazole versus fluconazole and voriconazole
2005
Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole
1992
The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000
2003
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues
1993
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Urbanisation and health in China
2012 Standout
The natural history of esophageal candidiasis after successful treatment in patients with AIDS
1994
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Cryptococcus gattiiInfection: Characteristics and Epidemiology of Cases Identified in a South African Province with High HIV Seroprevalence, 2002–2004
2006
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
1995
Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections
1998
Antibodies to GT1a ganglioside in patients with Guillain–Barré syndrome
1998
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs
2006
Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome
1993
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France
2005
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
From Exposure to Disease: The Role of Environmental Factors in Susceptibility to and Development of Tuberculosis
2001
Epidemiology of Cryptococcal Meningitis in the US: 1997–2009
2013
Voriconazole: therapeutic review of a new azole antifungal
2004
Voriconazole: A New Triazole Antifungal Agent
2003 Standout
Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis
1993
Resistant Candidiasis
1994
Paradoxical Inflammatory Reaction during Treatment of Cryptococcus neoformans var. gattii Meningitis in an HIV-Seronegative Woman
2004
Cryptococcosis in Children with AIDS
1999
Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
1993
Peripheral neuropathies and anti-glycolipid antibodies
2002
Neuroglial activation and neuroinflammation in the brain of patients with autism
2004 Standout
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
2007
Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen
2011
A Double‐Blind Comparison of Itraconazole Oral Solution and Fluconazole Capsules for the Treatment of Oropharyngeal Candidiasis in Patients with AIDS
1998
Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection
1995
Multiple perspectives on diagnosis delay for tuberculosis from key stakeholders in poor rural China: Case study in four provinces
2006
Cas1p is a membrane protein necessary for the O‐acetylation of the Cryptococcus neoformans capsular polysaccharide
2001
Epidemiology of the Guillain-Barré syndrome
2001
Quantifying the Association between <i>Campylobacter</i> Infection and Guillain-Barré Syndrome: A Systematic Review
2010
Haemophilus influenzae infection and Guillain-Barre syndrome
2000
Immunity to fungal infections
2011 Standout
Emerging fungal threats to animal, plant and ecosystem health
2012 StandoutNature
Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barr� syndrome: A reappraisal
1999
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
2009 Standout
Cryptococcosis
2002
Guillain-Barré syndrome
2005 Standout
Fluconazole
1995
Food-Related Illness and Death in the United States
1999 Standout
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome
1991
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
Diagnostic Yield of Sputum, Induced Sputum, and Bronchoscopy after Radiologic Tuberculosis Screening
2006
Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barre syndrome.
1996
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Candida Infections of Medical Devices
2004 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
INCUBATION TIME OF EPIDEMIC POLYARTHRITIS
1980
Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B
2002
Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh
2010
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Virulence factors of medically important fungi
1996
Infections in solid-organ transplant recipients
1997
Epidemiology of HIV-associated cryptococcosis in France (1985–2001)
2004
Guillain-Barr� syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies
1995
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Recapitulation of the Sexual Cycle of the Primary Fungal Pathogen Cryptococcus neoformans var. gattii : Implications for an Outbreak on Vancouver Island, Canada
2003
Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3
1996
A prospective study of acute idiopathic neuropathy. II. Antecedent events.
1988
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain–Barré syndrome (GBS)
1997
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis
1997
Hemicelluloses
2010 Standout
HLA and T-cell receptor gene polymorphisms in Guillain-Barre syndrome
1998
The Immune Response in Tuberculosis
2013 Standout
Inflammatory infiltrates in the spinal cord of patients with Guillain-Barr� syndrome
2003
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Comparison of commercial kits for detection of cryptococcal antigen
1994
Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance
1999
Aspergillus fumigatusand Aspergillosis
1999 Standout
Disseminated Phaeohyphomycosis: Review of an Emerging Mycosis
2002
Fluconazole, a New Antifungal Agent
1990
Housing and Health: Time Again for Public Health Action
2002
Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barre Syndrome Exhibit Mimicry of GM 1 Ganglioside
1998
Mild forms of Guillain-Barre syndrome in an epidemiologic survey in the Netherlands
2000
Cryptococcus Infection in Tropical Australia
2004
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
Cyclic AMP-Dependent Protein Kinase Controls Virulence of the Fungal Pathogen Cryptococcus neoformans
2001
Guidelines for Treatment of Candidiasis
2004 Standout
Socioeconomic Status and Health: The Potential Role of Environmental Risk Exposure
2002 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?
1994
Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis
2005 Standout
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
2008
Gastroenteritis-associated Guillain–Barre syndrome on the Caribbean Island Curacao
2001
Works of Bryan Speed being referenced
Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
1984
Clinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformans
1995
Two fatal infections in immunocompromised patients caused by scedosporium inflatum
1993
Control of HBV and HDV infection in an isolated pacific Island: 1. pattern of infection
1989
Health indicators and risks among people experiencing homelessness in Melbourne, 1995-1996
1998
Time to initiation of anti-tuberculosis treatment
1996
Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New Zealand
2000
Fatal disseminated infection by scedosporium prolificans during induction therapy for acute leukemia: a case report and literature review
1999
Efficacy of fluconazole in cryptococcal meningitis
1989
Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV‐infected patients: A double‐blind placebo‐controlled study
1993
Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects.
1996
Campylobacter jejuni/Campylobacter coli ‐associated Guillain‐Barré syndrome
1987
EPIDEMIC POLYARTHRITIS ACQUIRED IN FIJI
1980
Tuberculosis infection and homelessness in Melbourne, Australia, 1995-1996.
1999